![Robert Paccasassi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Paccasassi formerly worked at Merck KGaA, as Director-Quality Systems from 2011 to 2014 and BioRestorative Therapies, Inc., as Vice President-Quality & Regulatory Compliance from 2016 to 2024.
Mr. Paccasassi received his undergraduate degree from the University of Rhode Island and Masters Business Admin degree from Johnson & Wales University, Inc.
Anciens postes connus de Robert Paccasassi
| Sociétés | Poste | Fin |
|---|---|---|
| BIORESTORATIVE THERAPIES, INC. | Compliance Officer | 01/10/2024 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2014 |
Formation de Robert Paccasassi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Wales University, Inc.
 Johnson & Wales University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioRestorative Therapies, Inc.
 BioRestorative Therapies, Inc. Medical SpecialtiesHealth Technology Develops stem cell therapies to address unmet needs in patients with highly prevalent conditions | Health Technology |
